Alcohol use disorders (AUDs), and alcohol dependence (AD) in particular, are prevalent and associated with a large burden of disability and mortality. The aim of this study was to estimate prevalence of AD in the European Union (EU), Iceland, Norway, and Switzerland for the year 2010, and to investigate potential influencing factors. The 1-year prevalence of AD in the EU was estimated at 3.4% among people 18-64 years of age in Europe (women 1.7%, men 5.2%), resulting in close to 11 million affected people. Taking into account all people of all ages, AD, abuse and harmful use resulted in an estimate of 23 million affected people. Prevalence of AD varied widely between European countries, and was significantly impacted by drinking cultures and social norms. Correlations with level of drinking and other drinking variables and with major known outcomes of heavy drinking, such as liver cirrhosis or injury, were moderate. These results suggest a need to rethink the definition of AUDs.

Keywords:
Alcohol, Alcohol dependence, Alcohol use disorders, Heavy drinking, Prevalence, Liver cirrhosis, Injury, Europe
1.
World Health Organization: Global Health Risks. Mortality and Burden of Disease Attributable to selected Major Risks. Geneva, WHO, 2009.
2.
Rehm J, Mathers C, Popova S, Thavorncharoensap M, Teerawattananon Y, Patra J: Global burden of disease and injury and economic cost attributable to alcohol use and alcohol use disorders. Lancet 2009;373:2223-2233.
3.
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT, Byers TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, Chen H, Chen JS, Cheng T-A, Child JC, Cohen A, Colson KE, Cowie BC, Darby S, Darling S, Davis A, Degenhardt L, Dentener F, Des Jarlais DC, Devries K, Dherani M, Ding EL, Dorsey ER, Driscoll T, Edmond K, Ali SE, Engell RE, Erwin PJ, Fahimi S, Falder G, Farzadfar F, Ferrari A, Finucane MM, Flaxman S, Fowkes FG, Freedman G, Freeman MK, Gakidou E, Ghosh S, Giovannucci E, Gmel G, Graham K, Grainger R, Grant B, Gunnell D, Gutierrez HR, Hall W, Hoek HW, Hogan A, Hosgood HD III, Hoy D, Hu H, Hubbell BJ, Hutchings SJ, Ibeanusi SE, Jacklyn GL, Jasrasaria R, Jonas JB, Kan H, Kanis JA, Kassenbaum N, Kawakami N, Khang Y-H, Khatibzadeh S, Khoo J-P, Kok C, Laden F, Lalloo R, Lan Q, Lathlean T, Leasher JL, Leigh J, Li Y, Lin JK, Lipshultz SE, London S, Lozano R, Lu Y, Mak J, Malekzadeh R, Mallinger L, Marcenes W, March L, Marks RE, Martin RE, McGale P, McGrath J, Mehta S, Mensah GA, Merriman TR, Micha R, Michaud C, Mishra V, Hanafiah KM, Mokdad AA, Morawska L, Mozaffarian D, Murphy T, Naghavi M, Neal B, Nelson PK, Nolla JM, Norman R, Olives C, Omer SB, Orchard J, Osborne Rh, Ostro B, Page A, Pandey KD, Parry CD, Passmore E, Patra J, Pearce N, Pelizarri PM, Petzold M, Phillips MR, Pope D, Pope CA III, Powles J, Rao M, Razavi H, Rehfuess EA, Rehm JT, Ritz B, Rivara FP, Roberts T, Robinson C, Rodriguez-Portales JA, Romieu I, Room R, Rosenfeld LC, Roy A, Rushton L, Salomon JA, Sampson U, Sanchez-Riera L, Sanman E, Sapkota A, Seedat S, Shi P, Shield KD, Shivakoti R, Singh GM, Sleet DA, Smith E, Smith KR, Stapelberg NJ, Steenland K, Stöckl H, Stovner P, Straif K, Straney L, Thurston GD, Tran JH, Dingenen RV, Van Donkelaar A, Lennert Veerman J, Vijayakumar L, Weintraub R, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams W, WIlson N, Woolf AD, Yip P, Zielinski JM, Lopez AD, Murray CL, Ezzati M: A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224-2260.
4.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4: Primary Care. Washington, APA, 2000.
5.
World Health Organization: International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva, WHO, 2010.
6.
World Health Organization: The Global Burden of Disease: 2004 Update. Geneva, WHO, 2008.
7.
Roerecke M, Rehm J: Alcohol use disorders and mortality - a systematic review and meta-analysis. Addiction 2013;108:1562-1578.
8.
Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez G, Baxter A, Bell ML, Benjamin EJ, Bennett D, Bernabé E, Bhalla K, Bhandari B, Bikbov B, Abdulhak AB, Birbeck G, Black JA, Blencowe H, Blore JD, Blyth F, Bolliger I, Bonaventure A, Boufous S, Bourne R, Boussinesq M, Braithwaite T, Brayne C, Bridgett L, Brooker S, Brooks P, Brugha TS, Bryan-Hancock C, Bucello C, Buchbinder R, Buckle G, Budke CM, Burch M, Burney P, Burstein R, Calabria B, Campbell B, Canter CE, Carabin H, Carapetis J, Carmona L, Cella C, Charlson F, Chen H, Cheng AT-A, Chou D, Chugh SS, Coffeng CE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, Courville de Vaccaro K, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahiya M, Dahodwala N, Damsere-Derry J, Danaei G, Davis A, De Leo D, Degenhardt L, Dellavalle R, Delossantos A, Denenberg J, Derrett S, Des Jarlais DC, Dharmaratne SD, Dherani M, Diaz-Torne C, Dolk H, Dorsey ER, Driscoll T, Duber H, Ebel B, Edmond K, Elbaz A, Eltahir Ali S, Erskine H, Erwin PJ, Espindola P, Ewoigbokhan SE, Farzadfar F, Feigin V, Felson DT, Ferrari A, Ferri CP, Fèvre EM, Finucane MM, Flaxman S, Flood L, Foreman K, Forouzanfar MH, Fowkes FG, Fransen M, Freeman MK, Gabbe BJ, Gabriel SE, Gakidou E, Ganatra HA, Garcia B, Gaspari F, Gillum RF, Gmel G, Gonzalez-Medina D, Gosselin R, Grainger R, Grant B, Groeger J, Guillemin F, Gunnell D, Gupta R, Haagsma J, Hagan H, Halasa YA, Hall W, Haring D, Haro JM, Harrison JE, Havmoeller R, Hay RJ, Higashi H, Hill C, Hoen B, Hoffman H, Hotez PJ, Hoy D, Huang JJ, Ibeanusi SE, Jacobsen KH, James SL, Jarvis D, Jasrasaria R, Jayaraman S, Johns N, Jonas JB, Karthikeyan G, Kassebaum N, Kawakami N, Keren A, Khoo J-P, King CH, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Laden F, Lalloo R, Laslett LL, Lathlean T, Leasher JL, Lee YY, Leigh J, Levinson D, Lim SS, Limb E, Lin JK, Lipnick M, Lipshultz SE, Liu W, Loane M, Lockett Ohno S, Lyons R, Mabweijano J, MacIntyre MF, Malekzadeh R, Mallinger L, Manivannan S, Marcenes W, March L, Margolis DJ, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McGrath J, Medina Mora ME, Meltzer M, Mensah GA, Merriman TR, Meyer A-C, Miglioli V, Miller M, Miller TR, Mitchell PB, Mock C, Mocumbi AO, Moffitt TE, Mokdad AA, Monasta L, Montico M, Moradi-Lakeh M, Moran A, Morawska L, Mori R, Murdoch ME, Mwaniki MK, Naidoo K, Nair MN, Naldi L, Narayan KMV, Nevitt MC, Newton CR, Nolte S, Norman P, Norman R, O'Donnell M, O'Hanlon S, Olives C, Omer SB, Ortblad K, Osborne R, Ozgediz D, Page A, Pahari B, Pandian JD, Panozo Rivero A, Patten SB, Pearce N, Perez Padilla R, Perico N, Pesudovs K, Phillips D, Phillips MR, Pierce K, Pion S, Polanczyk GV, Polinder S, Pope CA III, Popova S, Porrini E, Pourmalek F, Prince M, Pullan RL, Ramaiah KD, Ranganathan D, Razavi H, Regan M, Rehm JT, Rein DB, Remuzzi G, Richardson K, Rivara FP, Roberts T, Robinson C, Rodriguez De León F, Ronfani L, Room R, Rosenfeld LC, Rushton L, Sacco RL, Saha S, Sampson U, Sanchez-Riera L, Sanman E, Schwebel DC, Scott JG, Segui-Gomez M, Shahraz S, Shepard DS, Shin H, Shivakoti R, Singh D, Singh GM, Singh JA, Singleton J, Sleet DA, Sliwa K, Smith E, Smith JL, Stapelberg NJC, Steer A, Steiner T, Stolk WA, Stovner LJ, Sudfeld C, Syed S, Tamburlini G, Tavakkoli M, Taylor HR, Taylor JA, Taylor WJ, Thomas B, Thomson WM, Thurston GD, Tleyjeh IM, Tonelli M, Towbin JA, Truelsen T, Tsilimbaris MK, Ubeda C, Undurraga EA, Van der Werf MJ, Van Os J, Vavilala MS, Venketasubramanian N, Wang M, Wang W, Watt K, Weatherall DJ, Weinstock MA, Weintraub R, Weisskopf MG, Weissman MM, White RA, Whiteford H, Wiebe N, Wiersma ST, Wilkinson JD, Williams HC, Williams SRM, Witt E, Wolfe F, Woolf AD, Wulf S, Yeh P-H, Zaidi AKM, Zheng ZJ, Zonies D, Lopez AD: Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2197-2223.
9.
Rehm J, Dawson D, Frick U, Gmel G, Roerecke M, Shield KD, Grant B: Burden of disease associated with alcohol use disorders in the United States. Alcohol Clin Exp Res 2014;38:1068-1077.
10.
Rehm J, Shield KD, Rehm MX, Gmel G Jr, Frick U: Alcohol Consumption, Alcohol Dependence, and Attributable Burden of Disease in Europe: Potential Gains from Effective Interventions for Alcohol Dependence. Toronto, Centre for Addiction and Mental Health, 2012.
11.
Rehm J, Shield KD, Rehm MX, Gmel G, Frick U: Modelling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. Eur Neuropsychopharmacol 2013;23:89-97.
12.
Walter SD: The estimation and interpretation of attributable risk in health research. Biometrics 1976;32:829-849.
13.
Roerecke M, Rehm J: Cause-specific mortality risk in alcohol use disorder treatment patients: a systematic review and meta-analysis. Int J Epidemiol 2014;43:906-919.
14.
Rehm J, Room R, Van den Brink W, Jacobi F: Alcohol use disorders in EU countries and Norway: an overview of the epidemiology. Eur Neuropsychopharmacol 2005;15:377-388.
15.
Üstün BT, Compton W, Mager D, Babor T, Baiyewu O, Chatterji S, Cottler L, Gogus A, Mavreas V, Peters L, Pull C, Saunders J, Smeets R, Stipec M, Vrasti R, Hasin D, Room R, Van den Brink W, Regier D, Blaine J, Grant BF, Sartorius N: WHO study on the reliability and validity of the alcohol and drug use disorder instruments. Overview of methods and results. Drug Alcohol Depend 1997;47:161-169.
16.
Pull CB, Saunders JB, Mavreas V, Cottler LB, Grant BF: Concordance between ICD-10 alcohol and drug use disorder criteria and diagnoses as measured by the AUDADIS-ADR, CIDI and SCAN: results of a cross-national study. Drug Alcohol Depend 1997;47:207-216.
17.
Hasin D: Classification of alcohol use disorders. Alcohol Res Health 2003;27:5-17.
18.
Hasin DS, Stinson FS, Grant BF: Prevalence, correlates, disability and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007;64:830-842.
19.
Samokhvalov AV, Popova S, Room R, Ramonas M, Rehm J: Disability associated with alcohol abuse and dependence. Alcohol Clin Exp Res 2010;34:1871-1878.
20.
World Health Organization: Global Status Report on Alcohol and Health. Geneva, WHO, 2014.
21.
World Health Organization: Composite International Diagnostic Interview: Authorized Core Version 1.0. Geneva, WHO, 1990.
22.
Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, Jablenski A, Regier D, Sartorius N: SCAN: Schedules for Clinical Assessment in Neuropsychiatry. Arch Gen Psychiatry 1990;47:589-593.
23.
Alonso J, Angermeyer M, Bernert S, Bruffaert R, Brugha T: Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESMeD) project. Acta Psychiatr Scand Suppl 2004;420:21-27.
24.
Grant BF, Compton WM, Crowley TJ, Hasin DS, Helzer JE, Li TK, Rounsaville BJ, Volkow ND, Woody GE: Errors in assessing DSM-IV substance use disorders. Arch Gen Psychiatry 2007;64:379-380.
25.
Okoliyski M, Zarkov Z, Broshtilov A, Hinkov H, Nakov V, Dinolova R, Dimitrov P, Tomov T: National representative epidemiological study of common psychiatric disorders in Bulgaria (2003-2007): twelve-month and lifetime prevalence, severity and co-morbidity. Bulg J Public Health 2010;II:2-13.
26.
Tomov T, Hinkov H, Zarkov Z, Mladenova M, Vasilev S, Okolijsky M: Nationally representative epidemiological study of common psychiatric disorders in Bulgaria (2002-2006): tools, methods, conduction and assessment. Soc Med 2008;4:16.
27.
Dzurova L, Smolova E, Dragomirecka E: Dusevni zdravi v sociodemografickych souvislostech (Vysledky vyberoveho setreni v Ceske republice) [Mental health in the sociodemographic context: results of a sample survey in the Czech Republic]. Prague, Prirodovedecka Fakulta UK, 2000.
28.
De Girolamo G, Polidori G, Morosini P, Scarpino V, Reda V, Serra G, Mazzi F, Alonso J, Vilagut G, Visona G, Falsirollo F, Rossi A, Warner R: Prevalence of common mental disorders in Italy: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD). Soc Psychiatry Psychiatr Epidemiol 2006;41:853-861.
29.
Florescu S, Moldovan M, Mihaescu-Pintia C, Ciutan M, Sorel GE: The Mental Health Study. Romania 2007. Prevalence, severity, and treatment of 12-Month DSM-IV disorders. Management Health 2009;13:23-31.
30.
Haro JM, Palacín C, Vilagut G, Martínez M, Bernal M, Luque I, Codony M, Dolz M, Alonso J; Grupo ESEMed-España: Prevalencia de los trastornos mentales y factores asociados: resultados del estudio ESEMeD-España [Prevalence of mental disorders and associated factors: results from the ESEMeD-Spain study]. Med Clin (Barc) 2006;126:445-451.
31.
Jacobi F, Wittchen H, Hölting C, Höfler M, Pfister H, Müller N, Lieb R: Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). Psychol Med 2004;34:1-15.
32.
Jacobi F, Wittchen H, Hölting C, Sommer S, Lieb R: Estimating the prevalence of mental and somatic disorders in the community: aims and methods of the German National Health Interview and Examination Survey. Int J Methods Psychiatr Res 2002;11:1-18.
33.
Üstün TB, Chatterji S, Villanueva M, Bendib L, Celik C, Sadana R, Valentine N, Ortiz J, Tandon A, Saloman J, Cao Y, Xie-Wan J, Ozaltin E, Mathers CD, Murray CJL: The WHO multicountry household survey study on health and responsiveness 2000-2001; in Murray CJL, Evans D (eds): Health Systems Performance Assessment: Debates, Methods and Empiricism. Geneva, WHO, 2003.
34.
Kuendig H: Alcohol dependence figures in the Swiss general population: a Sisyphean challenge for epidemiologists. Eur Addict Res 2010;16:185-192.
35.
World Health Organization Regional Office for Europe: European Status Report on Alcohol and Health 2010. Copenhagen, World Health Organization Regional Office for Europe, 2010.
36.
Babor T, Higgins-Biddle J, Saunders J, Monteiro M: AUDIT - The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care, ed 2. Geneva, WHO, 2001.
37.
Ewing JA: Detecting alcoholism: the CAGE questionnaire. JAMA 1984;252:1905-1907.
38.
United Nations Population Division: World Population Prospects: The 2008 Revision. New York, United Nations, 2009.
39.
Uhl A, Bachmayer S, Kobrna U, Puhm A, Springer A, Kopf N, Beiglböck W, Eisenbach-Stangl I, Preinsperger W, Musalek M: Handbuch: Alkohol - Österreich: Zahlen, Daten, Fakten, Trends 2009, 3rd rev ed. Vienna, Bundesministerium für Gesundheit, 2009.
40.
Jacobi F, Höfler M, Siegert J, Mack S, Gerschler A, Scholl L, Busch MA, Hapke U, Maske U, Seiffert I, Gaebel W, Maier W, Wagner M, Zielasek J, Wittchen HU: Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: the Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH). Int J Methods Psychiatr Res 2014;23:304-319.
41.
International Monetary Fund: World Economic Outlook Database. Washington, International Monetary Fund, 2013.
42.
Shield KD, Kehoe T, Gmel G, Rehm MX, Rehm J: Societal burden of alcohol; in Anderson P, Møller L, Galea G (eds): Alcohol in the European Union Consumption, Harm and Policy Approaches. Copenhagen, WHO Regional Office for Europe, 2012, pp 10-28.
43.
Rehm J, Kailasapillai S, Larsen E, Rehm MX, Samokhvalov AV, Shield KD, Roerecke M, Lachenmeier DW: A systematic review of the epidemiology of unrecorded alcohol consumption and the chemical composition of unrecorded alcohol. Addiction 2014;109:880-893.
44.
Rehm J, Rehn N, Room R, Monteiro M, Gmel G, Jernigan D, Frick U: The global distribution of average volume of alcohol consumption and patterns of drinking. Eur Addict Res 2003;9:147-156.
45.
Rehm J, Room R, Monteiro M, Gmel G, Graham K, Rehn N, Sempos CT, Frick U, Jernigan D: Alcohol use; in Ezzati M, Lopez AD, Rodgers A, Murray CJL (eds): Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Geneva, WHO, 2004, pp 959-1109.
46.
Rehm J, Klotsche J, Patra J: Comparative quantification of alcohol exposure as risk factor for global burden of disease. Int J Methods Psychiatr Res 2007;16:66-76.
47.
Rehm J, Kehoe T, Gmel G, Stinson F, Grant B, Gmel G: Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the example of the US. Popul Health Metr 2010;8:3.
48.
Kehoe T, Gmel GJ, Shield K, Gmel GS, Rehm J: Modelling alcohol consumption as a distribution and determining the impact of the distribution on estimated alcohol-attributable harms. Popul Health Metr 2012;10:6.
49.
World Health Organization: International Guide for Monitoring Alcohol Consumption and Related Harm. Geneva, WHO, 2000.
50.
Shield KD, Rylett MJ, Gmel G, Rehm J: Trends in alcohol consumption and alcohol-attributable mortality in the EU in 2010; in WHO Regional Office for Europe (ed): Status Report on Alcohol and Health in 35 European Countries. Copenhagen, WHO Regional Office for Europe, 2013.
51.
R Development Core Team: R: A Language and Environment for Statistical Computing, version 3.0.1. Vienna, Austria, R Foundation for Statistical Computing, 2013.
52.
Kringlen E, Torgersen S, Cramer V: Mental illness in a rural area: a Norwegian psychiatric epidemiological study. Soc Psychiatry Psychiatr Epidemiol 2006;41:713-719.
53.
Kraus L, Pabst A, Piontek D, Gomes de Matos E: Substanzkonsum und substanzbezogene Störungen: Trends in der deutschen Allgemeinbevölkerung 1980-2012. Sucht 2013;59:333-345.
54.
De Graaf R, Ten Have M, van Gool C, van Ddorsselaer S: Prevalence of mental disorders and trends from 1996 to 2009. Results from the Netherlands Mental Health Survey and Incidence Study-2. Soc Psychiatry Psychiatr Epidemiol 2012;47:203-213.
55.
Fuller E, Jotangia D, Farrell M: Alcohol misuse and dependence; in NHS Information Centre for Health and Social Care (ed): Adult Psychiatric Morbidity in England, 2007 Results of a Household Survey. London, The Health and Social Care Information Centre - Social Care Statistics, 2009.
56.
Gisle L, Hesse E, Driekens S, Demarest S, Van der Heyden J, Tafforeau J: Enquête de santé, 2008. Rapport II - Style de Vie et Prévention. Direction Opérationnelle Santé publique et surveillance. Bruxelles, Institut Scientifique de Santé Publique, 2010.
57.
Kraus L, Piontek D, Pabst A, Gomes de Matos E: Studiendesign und Methodik des Epidemiologischen Suchtsurveys 2012 [Study design and methodology of the 2012 Epidemiological Survey of Substance Abuse]. Sucht 2013;59:309-320.
58.
Bijl RV, Ravelli A, van Zessen G: Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 1998;33:587-595.
59.
Gmel G, Kuendig H, Notari L, Gmel C, Flury R: Suchtmonitoring Schweiz - Konsum von Alkohol, Tabak und illegaler Drogen in der Schweiz im Jahr 2012 [Addiction monitoring in Switzerland - Consumption of alcohol, tobacco and illegal drugs in Switzerland in the year 2012]. Lausanne, Sucht Schweiz, 2013.
60.
Notari L, Delgrande JM, Maffli E: Zusammenfassende Ergebnisse der Schweizerischen Gesundheitsbefragungen 2007, 2002, 1997 und 1992 hinsichtlich des Konsums von Tabak, Alkohol, Medikamenten und illegalen Drogen (Tabellenbericht zuhanden des Bundesamtes für Gesundheit) [Summary of results from the Swiss Health Surveys 1992, 1997 2002 and 2007 with respect to consumption of tobacco, alcohol, psychoactive medication and illegal drugs]. Lausanne, Schweizerische Fachstelle für Alkohol- und andere Drogenprobleme (SFA), 2009.
61.
American Psychiatric Association: Desk Reference to the Diagnostic Criteria from DSM-5. Washington, APA, 2013.
62.
Shield K, Rehm J: Difficulties with telephone-based surveys on alcohol in high-income countries: the Canadian example. Int J Methods Psychiatr Res 2012;21:17-28.
63.
Fazel S, Khosla V, Doll H, Geddes J: The prevalence of mental disorders among the homeless in Western countries: systematic review and meta-regression analysis. PLoS Med 2008;5:e225.
64.
Vollm B, Becker H, Kunstmann W: Psychiatrische Morbidität bei alleinstehenden wohnungslosen Männern [Psychiatric morbidity in homeless single men]. Psychiatr Prax 2004;31:236-240.
65.
Langle G, Egerter B, Albrecht F, Petrasch M, Buchkremer G: Prevalence of mental illness among homeless men in the community - approach to a full census in a southern German university town. Soc Psychiatry Psychiatr Epidemiol 2005;40:382-390.
66.
Lawless M, Corr C: Drug Use among the Homeless Population in Ireland. Dublin, Stationery Office, 2005.
67.
Fazel S, Bains P, Doll H: Substance abuse and dependence in prisoners: a systematic review. Addiction 2006;101:181-191.
68.
Linehan SA, Duffy DM, Wright B, Curtin K, Monks S, Kennedy HG: Psychiatric morbidity in a cross-sectional sample of male remanded prisoners. Irish J Psychol Med 2005;22:128-132.
69.
Jones GY, Hoffmann NG: Alcohol dependence: international policy implications for prison populations. Subst Abuse Treat Prev Policy 2006;1:33.
70.
Fotiadou M, Livaditis M, Manou I, Kaniotou E, Xenitidis K: Prevalence of mental disorders and deliberate self-harm in Greek male prisoners. Int J Law Psychiatry 2006;29:68-73.
71.
Manière-Haesebaert J, Sahajian F, Lamothe P, Fabry J: Characteristics of alcohol-dependent male inmates. Rev Epidemiol Sante Publique 2008;56:189-195.
72.
Roche AM, Freeman T, Skinner N: From data to evidence, to action: findings from a systematic review of hospital screening studies for high-risk alcohol consumption. Drug Alcohol Depend 2006;83:1-14.
73.
De Wit M, Jones DG, Sessler CN, Zilberberg MD, Weaver MF: Alcohol-use disorders in the critically ill patient. Chest 2010;138:994-1003.
74.
Toro PA, Tompsett CJ, Lombardo S, Philippot P, Nachtergael H, Galand B, Schlienz N, Stammel N, Yabar Y, Blume M, MacKay L, Harvey K: Homelessness in Europe and the United States: a comparison of prevalence and public opinion. J Soc Issues 2007;63:2007.
75.
Shield K, Rehm M, Patra J, Sornpaisarn B, Rehm J: Global and country-specific adult per capita consumption of alcohol, 2008. Sucht 2011;57:99-117.
76.
Schmidt LA, Mäkelä P, Rehm J, Room R: Alcohol: equity and social determinants; in Blas E, Kurup AS (eds): Equity, Social Determinants and Public Health Programmes. Geneva, WHO, 2010, pp 11-29.
77.
Room R: Taking account of cultural and societal influences on substance use diagnoses and criteria. Addiction 2006;101:31-39.
78.
Room R: Understanding cultural differences in young people's drinking; in Järvinen M, Room R (eds): Youth Drinking Cultures: European Experiences. Vermont, Ashgate Publishing, 2007, pp 17-40.
79.
Rehm J, Marmet S, Anderson P, Gual A, Kraus L, Nutt DJ, Room R, Samokhvalov AV, Scafato E, Trapencieris M, Wiers RW, Gmel G: Defining substance use disorders: do we really need more than heavy use? Alcohol Alcohol 2013;48:633-640.
80.
Rehm J, Anderson P, Gual A, Kraus L, Marmet S, Room R, Samokhvalov A, Scafato E, Shield K, Trapencieris M, Wiers R, Gmel G: The tangible common denominator of substance use disorders: a reply to commentaries to Rehm et al. (2013). Alcohol Alcohol 2014;49:118-122.
81.
Drummond C, Wolstenholme A, DeLuca P, Davey Z, Donoghue K, Elzerbi C, Gual A, Robles N, Goos C, Strizek J, Godfrey C, Mann K, Zois E, Hoffman S, Gmel G, Kuendig H, Scafato E, Gandin C, Reynolds J, Segura L, Colom J, Baena B, Coulton S, Kaner E: Alcohol interventions and treatments in Europe; in Anderson P, Braddick F, Reynolds J, Gual A (eds): Alcohol Policy in Europe: Evidence from AMPHORA, ed 2. AMPHORA, 2013.
82.
Wagenaar AC, Salois MJ, Komro KA: Effects of beverage alcohol price and tax levels on drinking: a meta-analysis of 1,003 estimates from 112 studies. Addiction 2009;104:179-190.
83.
Anderson P, Chisholm D, Fuhr D: Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet 2009;373:2234-2246.
84.
Chikritzhs T, Catalonao P, Pascal R: Predicting alcohol-related harms from licensed outlet density: a feasibility study. National Drug Law Enforcement Research Fund, 2007, Series No 28.
85.
Anderson P, De Bruijn A, Angus K, Gordon R, Hastings G: Impact of alcohol advertising and media exposure on adolescent alcohol use: a systematic review of longitudinal studies. Alcohol Alcohol 2009;44:229-243.
86.
Seitz HK, Stickel F: Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 2007;7:599-612.
87.
Powell AJ: Only in paradise: alcohol and Islam; in Robertson CK (ed): Religion and Alcohol: Sobering Thoughts. New York, Lang, 2004, pp 95-110.
88.
Kim W, Kim S: Women's alcohol use and alcoholism in Korea. Subst Use Misuse 2008;43:1078-1087.
89.
Bryden A, Roberts B, Petticrew M, McKee M: A systematic review of the influence of community level social factors on alcohol use. Health Place 2013;21:70-85.
90.
Schomerus G, Lucht M, Holzinger A, Matschinger H, Carta MG, Angermeyer MC: The stigma of alcohol dependence compared with other mental disorders: a review of population studies. Alcohol Alcohol 2011;46:105-112.
91.
Schomerus G, Matschinger H, Angermeyer MC: Continuum beliefs and stigmatizing attitudes towards persons with schizophrenia, depression and alcohol dependence. Psychiatr Res 2013;209:665-669.
92.
Nutt DJ, Rehm J: Doing it by numbers: a simple approach to reducing the harms of alcohol. J Psychopharmacol 2014;28:3-7.
93.
Rehm J, Roerecke M: Reduction of drinking in problem drinkers and all-cause mortality. Alcohol Alcohol 2013;48:509-513.
94.
Hansen ABG, Hvidtfeldt UA, Gronbaek M, Backer U, Nielsen AS, Tolstrup JS: The number of persons with alcohol problems in the Danish population. Scand J Public Health 2011;39:128-136.
95.
Rehn N, Room R, Edwards G: Alcohol in the European Region - Consumption, Harm and Policies. Copenhagen, WHO Regional Office for Europe, 2001.
96.
Latvala A, Tuulio-Henriksson A, Perälä J, Saarni S, Aalto-Setälä T, Aro H, Korhonen T, Koskinen S, Lönnqvist J, Kaprio J, Suvisaari J: Prevalence and correlates of alcohol and other substance use disorders in young adulthood: a population-based study. BMC Psychiatry 2009;9:73.
97.
Aromaa A, Koskinen S: Health and functional capacity in Finland baseline results on the Health 2000 Health Examination Survey. Helinski, National Public Health Institute, 2002.
98.
Pirkola SP, Isometsa E, Suvisaari J, Aro H, Joukamaa M, Poikolainen K, Koshinen S, Aromaa A, Lonnqvist JK: DSM-IV mood, anxiety and alcohol use disorders and their comorbidity in the Finnish general population. Results from the Health 2000 Study. Soc Psychiatry Psychiatr Epidemiol 2005;40:1-10.
99.
Lepine JP, Gasquet I, Kovess V, Arbabzadeh-Bouchez S, Negre-Pages L, Nachbaur G, Gaudin AF: Prevalence and comorbidity of psychiatric disorders in the French general population. Encephale 2005;31:182-194.
100.
Jacobi F, Mack S, Gerschler A, Scholl L, Höfler M, Siegert J, Bürkner A, Preiss S, Spitzer K, Busch M, Hapke U, Gaebel W, Maier W, Wagner M, Zielasek J, Wittchen HU: The design and methods of the mental health module in the German Health Interview and Examination Survey for Adults (DEGS1-MH). Int J Methods Psychiatr Res 2013;22:83-99.
101.
Jacobi F, Höfler M, Strehle J, Mack S, Gerschler A, Scholl L, Busch MA, Maske U, Gaebel W, Maier W, Wagner M, Zielasek J, Wittchen HU: Psychische Störungen in der Allgemeinbevölkerung: Studie zur Gesundheit Erwachsener in Deutschland und ihr Zusatzmodul Psychische Gesundheit (DEGS1-MH). Nervenarzt 2014;85:77-87.
102.
Stefansson JG, Lindal E: Algengi gedraskana a Stor-Reykjavikursvädinu [The prevalence of mental disorders in the greater Reykjavik area]. Laeknabladid [Icelandic Med J] 2009;95:559-566.
103.
Snikere S, Trapencieris M, Koroleva I, Mierina I, Priekule S, Aleksandrovs A, Jankovskis M: Atkari bu izraisoso vielu lietosana iedzi vota ju vidu 2011. Analitisks parskats. [Substance use among the population in 2011. Analytic report]. Riga, Slimibu profilakses un kontroles centrs, 2011.
104.
De Graaf R, Ten Have M, van Gool C, van Dorsselaer S: Prevalence of mental disorders and trends from 1996 to 2009. Results from the Netherlands Mental Health Survey and Incidence Study-2. Soc Psychiatry Psychiatr Epidemiol 2011;47:203-213.
105.
Kringlen E, Torgersen S, Cramer V: A Norwegian psychiatric epidemiological study. Am J Psychiatry 2001;158:1091-1098.
106.
Andréasson S, Danielsson AK, Hallgren M: Severity of alcohol dependence in the Swedish adult population: association with consumption and social factors. Alcohol 2013;47:21-25.
107.
World Health Organization: Global Status Report on Alcohol and Health. Geneva, WHO, 2004.
108.
Üstün TB, Chatterji S, Mechbal A, Murray CJL; WHS Collaborating Groups: The world health surveys; in Murray CJL, Evans D (eds): Health Systems Performance Assessment: Debates, Methods, and Empiricism. Geneva, WHO, 2003, pp 797-808.
109.
Kessler RC, Üstün B: The WHO World Mental Health Surveys. Global Perspectives of Mental Health Surveys, ed 1. New York, Cambridge University Press, 2008.
110.
Hoeck S, Van Hal G: Unhealthy drinking in the Belgian elderly population: prevalence and associated characteristics. Eur J Public Health 2012;23:1069-1075.
111.
Scafato E, Allamani A, Patussi V, Codenotti T, Marcomini F, Struzzo P; The Italian WHO Phase IV Eibi Working Group: Italy; in Heather N (ed): WHO Collaborative Project on Identification and Management of Alcohol-Related Problems in Primary Healthcare - Report on Phase IV. Geneva, WHO, 2005, pp 131-144.
112.
Shield KD, Rehm J, Gmel G, Rehm MX, Allamani A: Alcohol consumption, alcohol dependence, and related mortality in Italy in 2004: effects of treatment-based interventions on alcohol dependence. Subst Abuse Treat Prev Policy 2013;8:21.
113.
Manwell L, Ignaczak M, Czabala J: Prevalence of tobacco and alcohol use disorders in Polish primary care settings. Eur J Public Health 2002;12:139-144.
114.
Balsa C, Vital C, Urbano C III: Inquérito Nacional ao Consumo de Substâncias Psicoativas na População Portuguesa. Portugal 2013. Relatório Preliminar. Lisbon, Ministry of Health, 2013.
115.
Hällström T, Damsträm K, Forsell Y, Lundberg I, Tinghög P; The PART Study: A Population-Based Study of Mental Health in the Stockholm County. Study Design. Phase 1 (1998-2001). Stockholm, Karolinska Institutet, 2003.
116.
Tengström A, Ramstedt M, Sundin E, Hermansson K, Norman J, Rosendahl I: Slutrapportering av pilotstudien Vanor och konsekvenser - en nationell undersökning om tobak, alkohol, läkemedel och andra preparat. [Final report of the pilot study habits and consequences - a national survey of tobacco, alcohol, pharmaceuticals and illicit drugs]. Stockholm, FORUM - The Research Centre for Psycho-Social Health, 2012.
117.
National Institute for Health and Clinical Excellence: Alcohol Use Disorders: Diagnosis, Assessment and Management of Harmful Drinking and Alcohol Dependence. London, National Institute for Health and Clinical Excellence, 2011.
118.
McConnell P, Bebbington P, McClelland R, Gillespie K, Houghton S: Prevalence of psychiatric disorder and the need for psychiatric care in Northern Ireland. Br J Psychiatry 2002;181:214-219.
119.
Bunting B, Murphy S, O'Neill S, Ferry F: Prevalence and treatment of 12-month DSM-IV disorders in the Northern Ireland study of health and stress. Soc Psychiatry Psychiatr Epidemiol 2013;48:81-93.
120.
Rehm J, Room R, Monteiro M, Gmel G, Graham K, Rehn N, Sempos CT, Frick U, Jernigan D: Alcohol use; in Ezzati M, Lopez AD, Rodgers A, Murray CJL (eds): Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Geneva, WHO, 2004, vol 1, pp 959-1109.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.